Friday Letter 26/06/2020

Friday 26th June 2020

Shielding Patient Letters

Please be reminded of the following Shielding patient letters with an update on the relaxation of lockdown rules for those Shielding over the coming months.

Supply Disruption Alert: Phenelzine Sulphate 15mg tablets (Nardil®)

The Department of Health and Social Care (DHSC) and NHS England and Improvement (NHSE&I) have issued the following supply disruption alert for Phenelzine Sulphate 15mg tablets (Nardil®)

Action category:Action

Title:Phenelzine Sulphate 15mg tablets (Nardil) – Supply Disruption

Broadcast content:Phenelzine 15mg tablets (Nardil®) have been unavailable since August 2019 and this is now expected to be a long-term supply issue. There is currently no confirmed resupply date. 
Phenelzine is an irreversible monoamine oxidase inhibitor (MAOI) licensed for the treatment of depression clinically characterised as ‘atypical’, ‘non endogenous’, ‘neurotic’ or which has not responded to treatment with other antidepressants.It is clinically unsafe to stop or switch this drug abruptly, therefore, any switching or withdrawal will need to be undertaken by a specialist.
Unlicensed imports of phenelzine 15mg tablets were being used to manage patients and maintain treatment, however, due to global supply issues these imports have become unreliable.
Supplies of unlicensed phenelzine 15mg capsule specials have become available.
The alert contains further information and action for providers.
Please note that no response is required via the CAS website to this alert.

Additional information:NHS England and NHS Improvement Regional Offices: please cascade this alert to Community Pharmacy.

Alert reference:SDA/2020/011


Click here to view the full alert on the Central Alerting System.

PSNC Support documents for Pharmacy Audit

PSNC have published guidance regarding the upcoming pharmacy audit.

Guidance includes a team briefing outlining criteria or inclusion, what needs to be recorded and a series of FAQS; and an Audit template to support the preparation of data to be entered into PharmOutcomes.

For more information, please see the following links to the PSNC website:

Team briefing sheet

Audit template

CPCS helps 332, 000 patients

Please see the following message in last week’s NHS Primary Care Bulletin which states that there have been over 332,000 CPCS referrals over the past 7 months.

NHS Community Pharmacist Consultation Service helps 332,000 patients in first seven months

More than 180,000 consultations have taken place between patients and community pharmacists under the NHS Community Pharmacist Consultation Service (CPCS) since the NHS stepped up its response to COVID-19 at the end of January, bringing the total number of CPCS consultations since the service was introduced in October 2019 to over 332,000. The service, available at 94 per cent of community pharmacies in England via referral from NHS 111, enables patients to quickly access expert advice from a community pharmacist for a range of minor illnesses, or to get an urgent supply of a previously prescribed medicine.

Our Chief Pharmaceutical Officer Keith Ridge said “Pharmacies across England have put their all into supporting their communities during COVID-19 and made a real difference to so many patients and their families. Now, more than ever, access to same day advice and care via the CPCS is even more valued – as demonstrated by these high usage numbers. The achievement of 332,000 referrals since the service started is phenomenal and demonstrates once and for all how much trust the public places in NHS 111 and their local pharmacist. Thank you to everyone who has worked so hard to make this a success.”

GPHC – reviewing risk assessments in Community Pharmacy

GPHC has issued a statement advising pharmacy owners to review their current occupational risk assessment in light of the COVID-19 pandemic.

Click here to view the statement

RPS Inclusion and diversity strategy

RPS has published a report on inclusion and diversity for pharmacy 2020-2025. This report outlines changes to be implemented focusing on three priorities:

  • creating a culture of belonging,
  • championing inclusive and authentic leadership
  • challenging inclusion & diversity barriers

Click here to read the full report

The Impact of the Coronavirus Pandemic (COVID-19) on Community Pharmacies

A study is being conducted by Medway school of pharmacy and UCL to investigate the impact of the current coronavirus pandemic on Community Pharmacy Teams.

Please kindly take a few minutes to lend your support to this research by completing the following survey.

Click here to view

Thank you

Leave a Reply